Compendial Testing

USP Compendial Testing

US (CMC) and European (CTD) submissions often need to contain Certificates of Analysis (CoA) to prove compliance of the materials to the current US and European pharmacopoeias, respectively. Toxikon offers a wide range of physicochemical, in-vitro and in-vivo pharmacopoeial testing. 

 

What Do We Provide in Compendial Testing Program? 

United States Pharmacopoeia (USP) Testing

European Pharmacopeia (EP) Testing

Japanese Pharmacopoeia (JP) Testing

US FDA – CFR Testing

 

International Organization for Standardization (ISO)

  • ISO 3826-1
  • ISO 3826-4
  • ISO 9626

 

Toxikon Expertise in Compendial Testing 

Toxikon’s facilities and experienced laboratory management can offer the highest quality of work in compliance with ICH, OECD, ISO 17025 and many other globally-recognized standards. US (CMC) and European (CTD) submissions often need to contain Certificates of Analysis (CoA) to prove compliance of the materials to the current US and European pharmacopoeias, respectively. Toxikon offers a wide range of physicochemical, in-vitro and in-vivo pharmacopoeia testing. 

 

Compendial Testing
Compendial Testing, USP Pharmacopoeia Testing, USP 87 In-Vitro Biological Reactivity Cytotoxicity Testing, USP 88 In-Vivo Biological Reactivity Class I–VI Testing, USP 381 Elastomers, USP 661 Containers, E.P.Pharmacopoeia Testing, 3.1 Series; Materials used in the Manufacture of Pharmaceutical Containers, 3.2 Series; Containers, J.P.Pharmacopoeia Testing, US FDA CFR Testing
Toxikon offers a wide range of physicochemical, in-vitro and in-vivo pharmacopoeial testings. Contact us to learn more about USP Compendial Testing offerings.